Hohnloser SH - Search Results

1

Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting.

Cannon CP, Gropper S, Bhatt DL, Ellis SG, Kimura T, Lip GY, Steg PG, Ten Berg JM, Manassie J, Kreuzer J, Blatchford J, Massaro JM, Brueckmann M, Ferreiros Ripoll E, Oldgren J, Hohnloser SH; RE-DUAL PCI Steering Committee and Investigators. Cannon CP, et al. Among authors: hohnloser sh. Clin Cardiol. 2016 Oct;39(10):555-564. doi: 10.1002/clc.22572. Epub 2016 Aug 26. Clin Cardiol. 2016. PMID: 27565018 Free PMC article. Clinical Trial.

2

Efficacy and safety of sotalol in patients with complex ventricular arrhythmias.

Hohnloser SH, Zabel M, van de Loo A, Klingenheben T, Just H. Hohnloser SH, et al. Int J Cardiol. 1992 Dec;37(3):283-91. doi: 10.1016/0167-5273(92)90257-4. Int J Cardiol. 1992. PMID: 1281807 Review.

3

Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.

Hohnloser SH, van de Loo A, Baedeker F. Hohnloser SH, et al. J Am Coll Cardiol. 1995 Oct;26(4):852-8. doi: 10.1016/0735-1097(95)00286-5. J Am Coll Cardiol. 1995. PMID: 7560608 Free article. Clinical Trial.

4

Usefulness of CKMB and troponin T determinations in patients with acute myocardial infarction complicated by ventricular fibrillation.

Zabel M, Köster W, Hohnloser SH. Zabel M, et al. Among authors: hohnloser sh. Clin Cardiol. 1993 Jan;16(1):23-5. doi: 10.1002/clc.4960160105. Clin Cardiol. 1993. PMID: 8416755 Free article.

5

Drug treatment of atrial fibrillation: what have we learned?

Hohnloser SH, Li YG. Hohnloser SH, et al. Curr Opin Cardiol. 1997 Jan;12(1):24-32. doi: 10.1097/00001573-199701000-00005. Curr Opin Cardiol. 1997. PMID: 9132077 Review.

6

Pharmacological therapy of atrial fibrillation.

Grönefeld G, Bender B, Li YG, Hohnloser SH. Grönefeld G, et al. Among authors: hohnloser sh. Thorac Cardiovasc Surg. 1999 Aug;47 Suppl 3:334-8. doi: 10.1055/s-2007-1013194. Thorac Cardiovasc Surg. 1999. PMID: 10520763 Review.

7

Implantable devices versus antiarrhythmic drug therapy in recurrent ventricular tachycardia and ventricular fibrillation.

Hohnloser SH. Hohnloser SH. Am J Cardiol. 1999 Nov 4;84(9A):56R-62R. doi: 10.1016/s0002-9149(99)00702-x. Am J Cardiol. 1999. PMID: 10568661 Review.

8

Pharmacological management of atrial fibrillation: an update.

Hohnloser SH, Li YG, Bender B, Grönefeld G. Hohnloser SH, et al. J Cardiovasc Pharmacol Ther. 2000 Jan;5(1):11-6. doi: 10.1177/107424840000500102. J Cardiovasc Pharmacol Ther. 2000. PMID: 10687669 Review.

9

Adenosine-induced atrial fibrillation.

Israel C, Klingenheben T, Grönefeld G, Hohnloser SH. Israel C, et al. Among authors: hohnloser sh. J Cardiovasc Electrophysiol. 2000 Jul;11(7):825. doi: 10.1111/j.1540-8167.2000.tb00057.x. J Cardiovasc Electrophysiol. 2000. PMID: 10921803 No abstract available.

10

Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: results from a prospective study.

Grönefeld GC, Mauss O, Li YG, Klingenheben T, Hohnloser SH. Grönefeld GC, et al. Among authors: hohnloser sh. J Cardiovasc Electrophysiol. 2000 Nov;11(11):1208-14. doi: 10.1046/j.1540-8167.2000.01208.x. J Cardiovasc Electrophysiol. 2000. PMID: 11083241

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

550 results

Search Page